Related Experiment Video
Updated: Aug 14, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Practical management of atrial fibrillation
1Medical Service, Phoenix Veterans Affairs Medical Center, AZ 85012.
Insights
Managing atrial fibrillation involves rate control and identifying causes. Elective cardioversion can reduce stroke risk, while chronic cases need careful rate management and potential anticoagulation.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Atrial fibrillation (AF) management requires a multi-faceted approach.
- Key considerations include rate control, underlying condition identification, and therapeutic interventions.
Purpose of the Study:
- To outline optimal strategies for atrial fibrillation management.
- To emphasize the role of cardioversion in stroke prevention.
- To discuss appropriate rate control and anticoagulation in chronic AF.
Main Methods:
- Review of current guidelines and clinical practices for atrial fibrillation.
- Assessment of therapeutic options including cardioversion, rate-controlling medications, and anticoagulation.
- Consideration of patient-specific factors for treatment selection.
Main Results:
- Elective cardioversion is recommended for all patients to decrease embolic stroke incidence.
- Digoxin alone may be insufficient for rate control in active patients with chronic AF.
- Long-term anticoagulation benefits specific patient subgroups with chronic atrial fibrillation.
Conclusions:
- A comprehensive approach to atrial fibrillation management is crucial.
- Cardioversion plays a vital role in reducing stroke risk.
- Individualized treatment strategies for rate control and anticoagulation are essential for chronic AF.
Abstract:
Management of atrial fibrillation includes assessing the need for rate control, identifying underlying conditions, and performing cardioversion or instituting long-term medical therapy. Elective cardioversion should be strongly considered for every patient, chiefly to decrease the incidence of embolic stroke. Patients who remain in chronic atrial fibrillation require attention to rate control; digoxin (Lanoxin) alone may be a poor choice if they are vigorous and active. Many subgroups of patients benefit from long-term anticoagulation.
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias
Atherosclerosis III: Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

